{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T23:57:51Z","timestamp":1693353471513},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","revespcardiol.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.rec.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T16:19:07Z","timestamp":1496247547000},"page":"952-959","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety and Efficacy of Prasugrel and Ticagrelor in Acute Coronary Syndrome. Results of a \u201cReal World\u201d Multicenter Registry"],"prefix":"10.1016","volume":"70","author":[{"given":"Manuel","family":"Almendro-Delia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Garc\u00eda-Alc\u00e1ntara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Victoria","family":"de la Torre-Prados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Reina-Toral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Andr\u00e9s","family":"Arboleda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Butr\u00f3n-Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Garc\u00eda-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"de la Chica-Ruiz Ruano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Hidalgo-Urbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Garc\u00eda-Rubira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2017.05.003_bib0165","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2017.05.003_bib0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2017.05.003_bib0175","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1185\/03007995.2014.941055","article-title":"Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States","volume":"30","author":"Bae","year":"2014","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.rec.2017.05.003_bib0180","doi-asserted-by":"crossref","first-page":"e000849","DOI":"10.1161\/JAHA.114.000849","article-title":"Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry","volume":"3","author":"Sherwood","year":"2014","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.rec.2017.05.003_bib0185","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1016\/j.ijcard.2013.08.007","article-title":"Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the Greek Antiplatelet Registry (GRAPE)","volume":"168","author":"Alexopoulos","year":"2013","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2017.05.003_bib0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCOUTCOMES.111.000060","article-title":"Contemporary use of prasugrel in clinical practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium","volume":"6","author":"Sandhu","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"10.1016\/j.rec.2017.05.003_bib0195","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.amjcard.2015.02.049","article-title":"Contemporary use of ticagrelor in interventional practice (from Blue Cross Blue Shield of Michigan Cardiovascular Consortium)","volume":"115","author":"Karve","year":"2015","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2017.05.003_bib0200","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/imj.13041","article-title":"Clopidogrel, prasugrel or ticagrelor in patients with acute coronary s\u00edndromes undergoing percutaneous coronary intervention","volume":"46","author":"Yudi","year":"2016","journal-title":"Intern Med J."},{"key":"10.1016\/j.rec.2017.05.003_bib0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ccd.26279","article-title":"\u201cReal-World\u201d comparison of prasugrel with ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention in the United States","volume":"88","author":"Larmore","year":"2016","journal-title":"Catheter Cardiovasc Interv."},{"key":"10.1016\/j.rec.2017.05.003_bib0210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/ehjcvp\/pvw003","article-title":"Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on comtemporary European registries","volume":"2","author":"Danchin","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"10.1016\/j.rec.2017.05.003_bib0215","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ehjcvp\/pvw005","article-title":"P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries","volume":"2","author":"Zeymer","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"10.1016\/j.rec.2017.05.003_bib0220","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jth.13316","article-title":"Contemporary antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: 1-year outcomes from the GReek AntiPlatElet (GRAPE) Registry","volume":"14","author":"Alexopoulos","year":"2016","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.rec.2017.05.003_bib0225","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2147\/PPA.S68423","article-title":"Southern Saskatchewan Ticagrelor Registry experience","volume":"8","author":"Dehghani","year":"2014","journal-title":"Patient Prefer Adherence."},{"key":"10.1016\/j.rec.2017.05.003_bib0230","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2015.05.062","article-title":"Among antithrombotic agents, prasugrel, but not ticagrelor, is associated with reduced 30 day mortality in patients with ST-elevation myocardial infarction","volume":"195","author":"Serebruany","year":"2015","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2017.05.003_bib0235","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.116.024823","article-title":"Prasugrel versus Ticagrelor in Patients with Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study","volume":"134","author":"Motovska","year":"2016","journal-title":"Circulation."},{"issue":"A","key":"10.1016\/j.rec.2017.05.003_bib0240","first-page":"38","article-title":"Optimicemos el uso de los nuevos antiagregantes orales. Propuesta de protocolos comunes en el s\u00edndrome coronario agudo","volume":"14","author":"Roldan-Rabadan","year":"2014","journal-title":"Rev Esp Cardiol Supl."},{"key":"10.1016\/j.rec.2017.05.003_bib0245","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.recesp.2014.12.020","article-title":"Limitaciones al uso de los nuevos antiagregantes en los s\u00edndromes coronarios agudos relacionadas con las caracter\u00edsticas de los pacientes","volume":"68","author":"Lozano","year":"2015","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2017.05.003_bib0250","first-page":"273","article-title":"Monogr\u00e1fico Proyecto ARIAM. Concepto, desarrollo y objetivos","volume":"23","author":"\u00c1lvarez Bueno","year":"1999","journal-title":"Med Intensiva."},{"key":"10.1016\/j.rec.2017.05.003_bib0255","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1177\/2048872613517370","article-title":"Prognostic impact of atrial fibrillation in acute coronary syndromes: results from the ARIAM registry","volume":"3","author":"Almendro-Delia","year":"2014","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"key":"10.1016\/j.rec.2017.05.003_bib0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11239-014-1139-5","article-title":"Safety and efficacy of in-hospital clopidogrel-to-prasugrel switching in patients with acute coronary syndrome. An analysis from the \u2018real world\u2019","volume":"39","author":"Almendro-Delia","year":"2015","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.rec.2017.05.003_bib0265","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/106286060001500302","article-title":"Reducing time delay in the thrombolysis of myocardial infarction: An internal quality improvement project","volume":"15","author":"Saturno","year":"2000","journal-title":"Am J Med Qual."},{"key":"10.1016\/j.rec.2017.05.003_bib0270","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2017.05.003_bib0275","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis in Myocardial Infarction (TIMI) Trial","volume":"76","author":"Chesebro","year":"1987","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2017.05.003_bib0280","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.recesp.2011.06.008","article-title":"M\u00e9todos de puntuaci\u00f3n de propensi\u00f3n para crear una distribuci\u00f3n equilibrada de las covariables en estudios observacionales","volume":"64","author":"Pattanayak","year":"2001","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2017.05.003_bib0285","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput."},{"key":"10.1016\/j.rec.2017.05.003_bib0290","article-title":"The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes","author":"Austin","year":"2015","journal-title":"Stat Methods Med Res."},{"key":"10.1016\/j.rec.2017.05.003_bib0295","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/eurheartj\/ehw284","article-title":"Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry","volume":"37","author":"Sahl\u00e9n","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2017.05.003_bib0300","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.recesp.2015.12.021","article-title":"Cambios en el tratamiento y el pron\u00f3stico del s\u00edndrome coronario agudo con la implantaci\u00f3n del c\u00f3digo infarto en un hospital con unidad de hemodin\u00e1mica","volume":"69","author":"Cordero","year":"2016","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2017.05.003_bib0305","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archinte.167.10.1019","article-title":"Exploring the treatment-risk paradox in coronary disease","volume":"167","author":"McAlister","year":"2007","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.rec.2017.05.003_bib0310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000447396","article-title":"Real-world use of novel P2Y12 inhibitors in patients with acute myocardial infarction: A treatment paradox","volume":"136","author":"Beigel","year":"2016","journal-title":"Cardiology."},{"key":"10.1016\/j.rec.2017.05.003_bib0315","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.amjcard.2015.05.036","article-title":"Balancing long-term risks of ischemic and bleeding complications after percutaneous coronary intervention with drug-eluting stents","volume":"116","author":"Matteau","year":"2015","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2017.05.003_bib0320","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.recesp.2013.10.010","article-title":"Eficacia de los scores de riesgo hemorr\u00e1gico en el paciente anciano con s\u00edndrome coronario agudo","volume":"67","author":"Ariza-Sol\u00e9","year":"2014","journal-title":"Rev Esp Cardiol."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585717302700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585717302700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T04:40:06Z","timestamp":1535776806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585717302700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1885585717302700"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2017.05.003","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Prasugrel and Ticagrelor in Acute Coronary Syndrome. Results of a \u201cReal World\u201d Multicenter Registry","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}